Arbutus Biopharma Corp (NASDAQ:ABUS): Andreas Halvorsen’s Viking Global filed an amended 13D.
You can check out Viking Global’s latest holdings and filings here.
Please follow Viking Global (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Viking Global or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Viking Global Investors||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Performance||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Equities||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Equities II||0||0||0||16,013,540||16,013,540||29.1%|
|VGE III Portfolio Ltd||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Long Fund GP||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Long Fund Master Ltd||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Opportunities GP||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Opportunities Portfolio GP||0||0||0||16,013,540||16,013,540||29.1%|
|Viking Global Opportunities Illiquid Investments Sub-Master||0||0||0||16,013,540||16,013,540||29.1%|
|O. Andreas Halvorsen||0||0||0||16,013,540||16,013,540||29.1%|
|David C. Ott||0||0||0||16,013,540||16,013,540||29.1%|
|Rose S. Shabet||0||0||0||16,013,540||16,013,540||29.1%|
Page 1 of 17 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934
AMENDMENT NO. 3*
|Arbutus Biopharma Corporation|
|(Name of Issuer)|
|Common Shares, no par value|
|(Title of Class of Securities)|
55 Railroad Avenue
Greenwich, Connecticut 06830
|(Date of Event which Requires Filing of this Statement)|
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. ☐
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7
for other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 16 Pages)
* The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).